Published in Hepatology on January 10, 2011
Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog (2012) 2.04
Functions of autophagy in normal and diseased liver. Autophagy (2013) 1.81
ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol (2011) 1.50
Membranous replication factories induced by plus-strand RNA viruses. Viruses (2014) 1.40
Functions of autophagy in hepatic and pancreatic physiology and disease. Gastroenterology (2011) 1.35
Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. J Virol (2012) 1.17
Autophagy and viruses: adversaries or allies? J Innate Immun (2013) 1.10
Liver autophagy: much more than just taking out the trash. Nat Rev Gastroenterol Hepatol (2013) 1.05
Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy. Autophagy (2012) 1.05
Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication. J Virol (2014) 1.04
Manipulation or capitulation: virus interactions with autophagy. Microbes Infect (2011) 1.02
Divergent roles of autophagy in virus infection. Cells (2013) 1.01
West Nile virus (WNV) replication is independent of autophagy in mammalian cells. PLoS One (2012) 1.01
Autophagy in the control and pathogenesis of viral infection. Curr Opin Virol (2011) 1.00
HCV infection selectively impairs type I but not type III IFN signaling. Am J Pathol (2013) 0.97
Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases. Viruses (2012) 0.97
Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy. J Virol (2013) 0.95
Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells. J Virol (2011) 0.95
Impact of the autophagy machinery on hepatitis C virus infection. Viruses (2011) 0.95
Hepatitis C virus-induced autophagy is independent of the unfolded protein response. J Virol (2012) 0.94
Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection. Cell Mol Immunol (2014) 0.94
Japanese encephalitis virus activates autophagy as a viral immune evasion strategy. PLoS One (2013) 0.94
Modulation of the autophagy pathway by human tumor viruses. Semin Cancer Biol (2013) 0.93
Autophagy benefits the replication of Newcastle disease virus in chicken cells and tissues. J Virol (2013) 0.92
Autophagy and apoptosis in liver injury. Cell Cycle (2015) 0.92
Hepatitis C virus infection: establishment of chronicity and liver disease progression. EXCLI J (2014) 0.90
How positive-strand RNA viruses benefit from autophagosome maturation. J Virol (2013) 0.87
Knockdown of Autophagy Inhibits Infectious Hepatitis C Virus Release by the Exosomal Pathway. J Virol (2015) 0.86
Modulation of autophagy-like processes by tumor viruses. Cells (2012) 0.85
Atg7 deficiency impairs host defense against Klebsiella pneumoniae by impacting bacterial clearance, survival and inflammatory responses in mice. Am J Physiol Lung Cell Mol Physiol (2014) 0.84
Hepatitis C virus and autophagy. Biol Chem (2015) 0.84
Involvement of interleukin-1β in the autophagic process of microglia: relevance to Alzheimer's disease. J Neuroinflammation (2013) 0.84
New insights in recurrent HCV infection after liver transplantation. Clin Dev Immunol (2013) 0.83
Dengue Virus Inhibition of Autophagic Flux and Dependency of Viral Replication on Proteasomal Degradation of the Autophagy Receptor p62. J Virol (2015) 0.83
Atg7 enhances host defense against infection via downregulation of superoxide but upregulation of nitric oxide. J Immunol (2014) 0.82
Autophagy: a primer for the gastroenterologist/hepatologist. Can J Gastroenterol (2011) 0.80
The role of autophagy in intracellular pathogen nutrient acquisition. Front Cell Infect Microbiol (2015) 0.80
Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases. World J Gastroenterol (2014) 0.80
Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon. Autophagy (2015) 0.80
Coxsackievirus A16 elicits incomplete autophagy involving the mTOR and ERK pathways. PLoS One (2015) 0.79
Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy. World J Gastroenterol (2015) 0.79
Absence of autophagy promotes apoptosis by modulating the ROS-dependent RLR signaling pathway in classical swine fever virus-infected cells. Autophagy (2016) 0.78
The interplay of reovirus with autophagy. Biomed Res Int (2014) 0.78
The interaction between HCV and nuclear receptor-mediated pathways. Pharmacol Ther (2011) 0.78
Atg7 in development and disease: panacea or Pandora's Box? Protein Cell (2015) 0.78
Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response. Viruses (2016) 0.77
Enhanced Therapeutic Efficacy in Cancer Patients by Short-term Fasting: The Autophagy Connection. Front Oncol (2016) 0.77
Early events in the generation of autophagosomes are required for the formation of membrane structures involved in hepatitis C virus genome replication. J Gen Virol (2016) 0.77
Virus-drug interactions--molecular insight into immunosuppression and HCV. Nat Rev Gastroenterol Hepatol (2012) 0.77
Autophagy in HCV infection: keeping fat and inflammation at bay. Biomed Res Int (2014) 0.76
The Role of Autophagy in Lupus Nephritis. Int J Mol Sci (2015) 0.76
Bioimaging of Hyaluronate-Interferon α Conjugates Using a Non-Interfering Zwitterionic Fluorophore. Biomacromolecules (2015) 0.76
Interferon-inducible protein SCOTIN interferes with HCV replication through the autolysosomal degradation of NS5A. Nat Commun (2016) 0.75
Extracellular vesicles in liver diseases. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Suppression of Host Innate Immune Response by Hepatitis C Virus via Induction of Autophagic Degradation of TRAF6. J Virol (2016) 0.75
Porcine Epidemic Diarrhea Virus Induces Autophagy to Benefit Its Replication. Viruses (2017) 0.75
HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis. Oxid Med Cell Longev (2016) 0.75
Suppression of autophagy by mycophenolic acid contributes to inhibition of HCV replication in human hepatoma cells. Sci Rep (2017) 0.75
Foot-and-mouth disease virus infection suppresses autophagy and NF-кB antiviral responses via degradation of ATG5-ATG12 by 3C(pro). Cell Death Dis (2017) 0.75
Inhibition of p-IκBα Ubiquitylation by Autophagy-Related Gene 7 to Regulate Inflammatory Responses to Bacterial Infection. J Infect Dis (2015) 0.75
The autophagy elongation complex (ATG5-12/16L1) positively regulates HCV replication and is required for wild-type membranous web formation. Sci Rep (2017) 0.75
Atg7 Deficiency Intensifies Inflammasome Activation and Pyroptosis in Pseudomonas Sepsis. J Immunol (2017) 0.75
Nanoparticles increase human bronchial epithelial cell susceptibility to respiratory syncytial virus infection via nerve growth factor-induced autophagy. Physiol Rep (2017) 0.75
Autophagy and inflammation. Clin Transl Med (2017) 0.75
Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature (1999) 23.62
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med (2006) 18.63
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature (2008) 11.39
The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol (2007) 8.98
Replication of hepatitis C virus. Nat Rev Microbiol (2007) 8.31
Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science (2007) 7.65
HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe (2007) 7.34
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature (2008) 6.25
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A (2006) 4.84
Global challenges in liver disease. Hepatology (2006) 4.55
Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci U S A (2009) 4.48
Autophagy regulates programmed cell death during the plant innate immune response. Cell (2005) 4.18
The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci U S A (2007) 3.93
Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe (2009) 3.79
Autophagy genes in immunity. Nat Immunol (2009) 3.76
Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res (2007) 3.49
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials (2004) 3.46
The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci U S A (2009) 2.91
Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology (2008) 2.66
Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol (2007) 1.96
Generation of infectious hepatitis C virus in immortalized human hepatocytes. J Virol (2006) 1.86
Viruses and the autophagy machinery. Cell Cycle (2010) 1.68
Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology (2009) 1.62
Autophagy is involved in influenza A virus replication. Autophagy (2009) 1.60
Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy (2009) 1.60
Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes. J Gen Virol (2010) 1.52
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology (2008) 1.52
Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes. J Gen Virol (2009) 1.51
Rotavirus NSP4 induces a novel vesicular compartment regulated by calcium and associated with viroplasms. J Virol (2006) 1.49
Autophagy and antiviral immunity. Curr Opin Immunol (2008) 1.44
Autophagy in viral replication and pathogenesis. Mol Cells (2010) 1.23
Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J Virol (2007) 1.12
Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes. J Virol (2010) 1.11
Viral interactions with macroautophagy: a double-edged sword. Virology (2010) 1.10
IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53. Cancer Res (2009) 1.09
Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy. J Gastroenterol (2009) 1.08
Survival of parvovirus B19-infected cells by cellular autophagy. Virology (2006) 1.08
Hepatitis C virus: viral proteins on the move. Biochem Soc Trans (2009) 1.00
Hepatitis C Virus in the HIV-infected patient. Clin Liver Dis (2006) 0.97
Emerging strategies for pegylated interferon combination therapy. Nat Clin Pract Gastroenterol Hepatol (2007) 0.82
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet (2009) 4.58
Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med (2007) 4.42
Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol (2007) 1.96
Generation of infectious hepatitis C virus in immortalized human hepatocytes. J Virol (2006) 1.86
Functions of autophagy in normal and diseased liver. Autophagy (2013) 1.81
Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression. Hepatology (2013) 1.79
Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. Cancer Res (2002) 1.79
Classical ctxB in Vibrio cholerae O1, Kolkata, India. Emerg Infect Dis (2009) 1.53
ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol (2011) 1.50
miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol Cancer Ther (2012) 1.45
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. Vaccine (2010) 1.28
MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer (2010) 1.28
Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology (2002) 1.26
Superior vena cava syndrome secondary to saphenous venous graft aneurysm with right atrial fistula. Catheter Cardiovasc Interv (2003) 1.25
Oncogenic potential of hepatitis C virus proteins. Viruses (2010) 1.22
Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res (2010) 1.22
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. J Infect Dis (2006) 1.19
Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J Virol (2006) 1.19
Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. J Virol (2012) 1.17
Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect. J Virol (2006) 1.16
Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity. Genes Cancer (2011) 1.15
Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol (2012) 1.15
Hepatitis C virus infection, microRNA and liver disease progression. World J Hepatol (2013) 1.14
Identification of a small-molecule entry inhibitor for filoviruses. J Virol (2011) 1.14
Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J Virol (2007) 1.12
Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes. J Virol (2010) 1.11
Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol (2008) 1.11
Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. J Virol (2007) 1.10
Deficits in heel-rise height and achilles tendon elongation occur in patients recovering from an Achilles tendon rupture. Am J Sports Med (2012) 1.09
Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. J Virol (2012) 1.09
Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology (2006) 1.08
Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology (2002) 1.08
Bitter melon: antagonist to cancer. Pharm Res (2010) 1.08
Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein. J Virol (2002) 1.06
Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients. J Infect Dis (2002) 1.06
Hepatitis C virus proteins inhibit C3 complement production. J Virol (2011) 1.06
Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology (2011) 1.06
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology (2005) 1.05
Transcriptional repression of C4 complement by hepatitis C virus proteins. J Virol (2011) 1.04
Vibrio cholerae O1 clinical strains isolated in 1992 in Kolkata with progenitor traits of the 2004 Mozambique variant. J Med Microbiol (2009) 1.04
Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer. J Virol (2004) 1.02
Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J Virol (2010) 1.00
Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. FEBS Lett (2003) 1.00
c-myc Promoter-binding protein 1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway. J Biol Chem (2005) 0.99
Hepatitis C virus core protein augments androgen receptor-mediated signaling. J Virol (2008) 0.98
Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. Genes Cancer (2010) 0.97
Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages. J Virol (2013) 0.97
Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells. Virology (2004) 0.96
Antibody-dependent enhancement of hepatitis C virus infection. J Virol (2007) 0.96
Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model. Cancer Prev Res (Phila) (2011) 0.96
A comparison of the Glasgow Coma Scale score to simplified alternative scores for the prediction of traumatic brain injury outcomes. Ann Emerg Med (2005) 0.96
Hepatitis C virus core protein interacts with fibrinogen-beta and attenuates cytokine stimulated acute-phase response. Hepatology (2010) 0.95
Carboxyl-terminal repressor domain of MBP-1 is sufficient for regression of prostate tumor growth in nude mice. Cancer Res (2005) 0.95
Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology (2004) 0.95